Citations 1
Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)
Wang, Victoria , Ansell, Stephen M. , Mehta-Shah, N, Amengual, Jennifer E. , Cole, Peter D. , Forlenza, Christopher J. , Jegede, O, Steidl, Christian , Natkunam, Yasodha , Scott, David W. , Kahl, Brad S. , Diefenbach, Catherine
Klinische Pädiatrie | December 3, 2025 | Volume: 237 | Issue: No issue available | Pages: No page available
